Analysis of Complement Factor H gene polymorphisms and their association with clinical manifestations ofleptospirosis

Author(s):Show less -

Santiesteban-Lores, Lazara Elena ; Midon, Leonardo Moura ; Franco, Thirsaalvares ; de Oliveira, Luciano Marcondes ; Hibi, Sumire ; Chiani, Yosena ; Meneses, Gdaylloncavalcante ; Daher, Elizabeth De Francesco ; Fonseca, Denise Moraes ; Pontillo, Alessandra ; Isaac, Lourdes

• Document type: Journal article
• Source: IMMUNOGENETICS; v. 77, n. 1, p. 11-pg., 2025-12-01.

Abstract

Leptospirosis is caused by pathogenic leptospires, posing a significant public health problem. Host susceptibility to Leptospira infection is a multifactorial trait, and the host's genetic background can influence both the establishment of infection and the severity of the disease. Complement Factor H (FH) plays a crucial role in the interaction between pathogenic bacteria and the host. Genetic variants in the FH gene CFH have previously been associated with non-infectious diseases. Here, we aimed to analyze the effect of CFH variants on individual susceptibility to leptospirosis and disease severity. To accomplish this, we sequenced CFH exons 7, 9, 21, 22, and 23 in a case/control cohort (184/162) from two endemic leptospirosis areas in Brazil and Argentina. We identified twenty-one single nucleotide variants (SNVs). In the Brazilian cohort, the intronic variant rs34815383 exhibited a higher frequency in patients than in controls, resulting in a significant association with leptospirosis (p = 0.032; OR: 0.32; 95% CI 0.1-1) and also renal disorder (p = 0.001; OR: 5.3; 95%CI 1.8-15.57). This SNV is reported to be a splicing variant, negatively impacting CFH expression, and has previously been associated with Complement-driven renal disease. A second synonymous variant, rs61822181, was significantly less frequent in patients than in controls (p = 0.002; OR: 7.33; 95% CI 1.59-33.7), representing a protective factor against the development of leptospirosis. Our study represents the first documentation of the frequency of CFH SNVs in South America and identifies the variant rs34815383 T > C as a risk factor for leptospirosis and leptospirosis-related renal complications. (AU)

• FAPESP's process: 17/12924-3 - Etiopathogenesis of Leptospirosis: contribution of the complement system for the control of infection in vivo and in vitro and inflammatory response: identification of gene polymorphisms of the complement system in Leptospirosis patients
• Grantee: Lourdes Isaac
• Support Opportunities: Research Projects - Thematic Grants